Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Baldini

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
American Journal of Clinical Oncology|April 1, 1991
Combination chemotherapy and interferon alpha 2b in the treatment of advanced non-small-cell lung cancer. The Italian Lung Cancer Task Force (FONICAP)A Ardizzoni, R Rosso, F Salvati, et al.
Acta Medica Austriaca|January 1, 1989
Intraperitoneal infusion of recombinant interleukin-2 in malignant ascites in patients with gastrointestinal and ovarian cancerS Bertoglio, G Melioli, E Baldini, et al.
Seminars in Oncology|December 1, 1996
Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancerP F Conte, E Baldini, A Michelotti, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markersP Collecchi, E Baldini, P Giannessi, et al.
Seminars in Oncology|February 1, 1996
Activity and safety of epirubicin plus paclitaxel in advanced breast cancerP F Conte, A Michelotti, E Baldini, et al.
American Journal of Clinical Oncology|December 1, 1996
Phase II study of oral doxifluridine in elderly patients with advanced non-small-cell lung cancerE Baldini, C Tibaldi, E Pfanner, et al.
Anticancer Research|September 1, 1992
Prognostic factors in node positive primary breast cancer patients treated with adjuvant CMFE Campora, P Pronzato, D Amoroso, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Accelerated chemotherapy with or without GM-CSF for small cell lung cancer: a non-randomised pilot studyA Ardizzoni, M R Sertoli, A Corcione, et al.
Breast Cancer Research and Treatment|August 8, 1998
Epirubicin/vinorelbine as first line therapy in metastatic breast cancerE Baldini, C Tibaldi, F Chiavacci, et al.
British Journal of Cancer|April 20, 2006
Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I-II studyC Tibaldi, T Prochilo, F Russo, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
American Journal of Clinical Oncology|April 1, 1991
Combination chemotherapy and interferon alpha 2b in the treatment of advanced non-small-cell lung cancer. The Italian Lung Cancer Task Force (FONICAP)A Ardizzoni, R Rosso, F Salvati, et al.
Acta Medica Austriaca|January 1, 1989
Intraperitoneal infusion of recombinant interleukin-2 in malignant ascites in patients with gastrointestinal and ovarian cancerS Bertoglio, G Melioli, E Baldini, et al.
Seminars in Oncology|December 1, 1996
Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancerP F Conte, E Baldini, A Michelotti, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markersP Collecchi, E Baldini, P Giannessi, et al.
Seminars in Oncology|February 1, 1996
Activity and safety of epirubicin plus paclitaxel in advanced breast cancerP F Conte, A Michelotti, E Baldini, et al.
American Journal of Clinical Oncology|December 1, 1996
Phase II study of oral doxifluridine in elderly patients with advanced non-small-cell lung cancerE Baldini, C Tibaldi, E Pfanner, et al.
Anticancer Research|September 1, 1992
Prognostic factors in node positive primary breast cancer patients treated with adjuvant CMFE Campora, P Pronzato, D Amoroso, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Accelerated chemotherapy with or without GM-CSF for small cell lung cancer: a non-randomised pilot studyA Ardizzoni, M R Sertoli, A Corcione, et al.
Breast Cancer Research and Treatment|August 8, 1998
Epirubicin/vinorelbine as first line therapy in metastatic breast cancerE Baldini, C Tibaldi, F Chiavacci, et al.
British Journal of Cancer|April 20, 2006
Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I-II studyC Tibaldi, T Prochilo, F Russo, et al.
Pageof 12